Pradaxa Description

Pradaxa 75 mg: Capsule with a white opaque cap and a white opaque body, imprinted in black with BI company symbol on cap and "R75" on body.
Pradaxa 110 mg: Capsule with a light blue opaque cap and a light blue opaque body, imprinted in black with BI company symbol on cap and "R110" on body.
Pradaxa 150 mg: Capsule with a light blue opaque cap and a white opaque body, imprinted in black with BI company symbol on cap and "R150" on body.
1 Capsule contains 86.48 mg, 126.83 mg or 172.95 mg of beta-alanine, N-[[2-[[[4(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester, methane-sulfonate, being the methane sulfonic acid salt (corresponding to dabigatran etexilate base form 75 mg, 110 mg or 150 mg).
Excipients/Inactive Ingredients: Tartaric acid, acacia, hypromellose, dimethicone 350, talc, hydroxypropyl cellulose.
HPMC capsule shell: Carrageenan, potassium chloride, titanium dioxide, Indigo Carmine (E132), hypromellose.
Printing ink: Shellac, butyl alcohol, isopropyl alcohol, Iron oxide black (E172), purified water, propylene glycol, anhydrous ethanol, potassium hydroxide, concentrated ammonia solution.